THE PHARMACOLOGY OF PRODRUGS OF 5-FLUOROURACIL AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE

被引：33

作者：

HADFIELD, AF

SARTORELLI, AC

机构：

[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT PHARMACOL,NEW HAVEN,CT 06510

[2] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEV THERAPEUT PROGRAM,NEW HAVEN,CT 06510

来源：

ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY | 1984年 / 20卷

关键词：

D O I：

10.1016/S1054-3589(08)60264-1

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：21 / 67

页数：47

共 275 条

[1] ABELE R, 1982, CANCER TREAT REP, V66, P1307
[2] CHEMICAL ASPECTS OF SELECTIVE TOXICITY
ALBERT, A
[J]. NATURE, 1958, 182 (4633) : 421 - 423
[3] ALBERTO P, 1977, P AM ASSOC CANC RES, V18, P231
[4] ALBERTO P, 1976, CANCER TREAT REP, V60, P281
[5] PHASE-2 STUDY OF ANHYDRO-ARA-5-FLUOROCYTIDINE IN ADENOCARCINOMA OF GASTROINTESTINAL-TRACT, EPIDERMOID CARCINOMA OF LUNG, HEAD AND NECK, BREAST CARCINOMA AND SMALL CELL ANAPLASTIC CARCINOMA OF LUNG - STUDY REPORT OF EORTC EARLY CLINICAL TRIAL COOPERATIVE GROUP
ALBERTO, P
ROZENCWEIG, M
GANGJI, D
BRUGAROLAS, A
CAVALLI, F
SIEGENTHALER, P
HANSEN, HH
SYLVESTER, R
[J]. EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) : 195 - 201
[6] Amidon G. L., 1977, DESIGN BIOPHARMACEUT, P281
[7] AOSHIMA M, 1976, CANCER RES, V36, P2726
[8] AOSHIMA M, 1977, CANCER RES, V37, P2481
[9] ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[10] AU JL, 1979, CANCER RES, V39, P4289